At Memorial Hermann, personalized, integrated health care begins with your primary care provider (PCP).
Whether you are looking for routine wellness care and prevention or chronic-disease management and coordination with specialists, a PCP is your dedicated health partner through each stage of your life. Your PCP utilizes the latest research and technology to keep you healthy, and to diagnose and manage illness when you are not.
Diabetes is a chronic disease characterized by a difficulty in managing glucose, a sugar that is found in much of the food we eat. Effective glucose management can be evaluated by a blood test called Hemoglobin A1c (HbA1c). Optimal control is signaled by a test score of less than 9. Medical management, diet and exercise are required to optimize a diabetic patient’s wellness and minimize the risk of complications such as heart disease, kidney disease and loss of circulation. Recognizing that management of diabetes is critical to improving patient outcomes, Memorial Hermann developed multiple work efforts to address outpatient diabetic care:
As a result, the Memorial Hermann ACO patients performed better than the ACO cohort mean for ACO-27 Hemoglobin A1c Poor Control (>9%).
By decreasing the number of patients with a Hb A1c greater than nine, Memorial Hermann demonstrated more successful management among its adult patients, aged 18 to 75 years.
*Lower score (<9%) indicates better diabetic management
Among cancers that affect both men and women, colorectal cancer is the second most common cancer and the second leading cause of cancer-related death in the United States.
The most effective way to reduce the risk of colorectal cancer is routine screening, beginning at age 45, for people who are at average risk. Screening tests can find precancerous polyps so they can be removed before they turn into cancer. Screening tests also can find colorectal cancer earlier, when treatment may be more effective.
Recognizing that management of colorectal cancer screening is critical to improving patient outcomes, Memorial Hermann developed multiple work efforts to detect colorectal earlier:
Thanks to these efforts, results for the Memorial Hermann ACO patients were better than the ACO cohort mean for ACO-19 Colorectal Screening from 2019 to 2021.
Breast cancer is the most common cancer affecting women in the United States. While mammography screenings are proven to reduce breast cancer mortality rates, many women forgo the annual exams.
Recognizing that encouragement of breast cancer screening is critical to improving patient outcomes, Memorial Hermann developed a campaign to increase access to mammography screening for women.
Thanks to these efforts, results for the Memorial Hermann ACO patients were better than the ACO cohort men for ACO-20 Breast Cancer Screening from 2019 to 2021.
|Measure Name||Rate||ACO Mean|
|Diabetes: Hemoglobin A1c (HbA1c) Poor Control2||10.19||12.46|
|Falls: Screening for Future Fall Risk||92.91||87.03|
|Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention||85.71||80.97|
|Colorectal Cancer Screening||91.07||73.63|
|Breast Cancer Screening||79.30||75.11|
All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC)2
Quality performance results are based on CMS Web Interface
 A lower rate corresponds to higher quality.